Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-24-110570
Filing Date
2024-10-22
Accepted
2024-10-22 16:17:53
Documents
1
Group Members
5AM OPPORTUNITIES II (GP), LLC5AM OPPORTUNITIES II, L.P.5AM PARTNERS VI, LLCANDREW J. SCHWABDR. KUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2426593d1_sc13d.htm SC 13D 154496
  Complete submission text file 0001104659-24-110570.txt   156313
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Subject) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94655 | Film No.: 241386524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111 (415) 993-8565
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D